发明名称 Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity
摘要 The present invention relates to a pyrazole compound having potent CB1-antagonizing activity, having the following formula [I]: wherein R1 and R2 are the same or different and an optionally substituted aryl group etc., R3 is an alkyl group etc., E is one of the following groups of the formula (i) to (iv): Q1 is a single bond, an alkylene group or a group of the formula: —N(R7)—, R7 is a hydrogen atom or an alkyl group, Q2 is a single bond, an oxygen atom or an alkylene group, R4 is a cycloalkyl group, a group of the formula: —N(R5)(R6) etc., one of R5 and R6 is a hydrogen atom or an alkyl group and the other is an alkyl group, a group of the formula: —N(R8)(R9) etc., D is an oxygen atom etc., RA1 is an amino group etc., RA2 is an optionally substituted aliphatic heterocyclic group, R is an alkyl group optionally substituted by one to three halogen atom(s) etc., one of R8 and R9 is a hydrogen atom or an alkyl group and the other is an alkyl group etc., or a pharmaceutically acceptable salt thereof.
申请公布号 US7872006(B2) 申请公布日期 2011.01.18
申请号 US20060083610 申请日期 2006.10.20
申请人 MITSUBISHI TANABE PHARMA CORPORATION 发明人 MORITANI YASUNORI;IMASHIRO RITSUO;SATO ATSUSHI
分类号 A61K31/5377;A61K31/4155;A61K31/435;A61K31/496;C07D231/10;C07D401/02;C07D403/02;C07D413/02 主分类号 A61K31/5377
代理机构 代理人
主权项
地址